BP

433.15

-0.68%↓

BP

433.15

-0.68%↓

BP

433.15

-0.68%↓

BP

433.15

-0.68%↓

BP

433.15

-0.68%↓

Search

Smith & Nephew PLC

Fermé

1,081.5 -0.14

Résumé

Variation du prix de l'action

24h

Actuel

Min

1071

Max

1094.5

Chiffres clés

By Trading Economics

Revenu

107M

Ventes

1.4B

P/E

Moyenne du Secteur

30

28.777

BPA

0.376

Rendement du dividende

2.71

Marge bénéficiaire

7.57

Employés

17,349

EBITDA

260M

Recommandations

By TipRanks

Recommandations

Achat

Prévisions sur 12 Mois

+15.09% upside

Dividendes

By Dow Jones

Rendement du dividende

Moyenne du Secteur

2.71%

5.16%

Statistiques du Marché

By TradingEconomics

Capitalisation Boursière

520M

9.5B

Ouverture précédente

1081.64

Clôture précédente

1081.5

Smith & Nephew PLC Graphique

Les performances passées ne sont pas un indicateur fiable des résultats futurs.

Actualités Associées

31 mars 2025, 22:45 UTC

Actualités

Intel's New CEO Plots Turnaround; 'We Need to Improve'

31 mars 2025, 23:54 UTC

Market Talk

Nikkei May Rise After Monday's Selloff -- Market Talk

31 mars 2025, 23:44 UTC

Market Talk

Gold Edges Higher Amid Prospects of Broader, Higher U.S. Tariffs -- Market Talk

31 mars 2025, 23:15 UTC

Market Talk

Tower Shares Ease After Bain Capital Exit -- Market Talk

31 mars 2025, 23:15 UTC

Market Talk

Global Equities Roundup: Market Talk

31 mars 2025, 22:33 UTC

Actualités

Trump Administration Targets Harvard With Review of $9 Billion in Federal Funding -- Update

31 mars 2025, 22:28 UTC

Résultats

China Vanke: Weak China Real-Estate Market Weighed on Results >000002.SZ

31 mars 2025, 22:28 UTC

Résultats

China Vanke 2024 Loss CNY49.48B Vs. Net CNY12.16B >000002.SZ

31 mars 2025, 22:28 UTC

Résultats

China Vanke 2024 Rev CNY343.18B Vs. CNY465.74B >000002.SZ

31 mars 2025, 22:28 UTC

Résultats

China Vanke Swings to Loss for 2024 >000002.SZ

31 mars 2025, 21:47 UTC

Actualités

Intel's New CEO Says Turnaround 'Won't Be Easy' -- Barrons.com

31 mars 2025, 21:44 UTC

Actualités

Trump Administration Targets Harvard With Review of $9 Billion in Federal Funding -- WSJ

31 mars 2025, 21:21 UTC

Market Talk

Intel Has 'A Lot of Hard Work Ahead' in Turnaround, CEO Says -- Market Talk

31 mars 2025, 21:18 UTC

Actualités

Copper Is 2025's Hottest Commodity -- Update

31 mars 2025, 21:09 UTC

Actualités

Senate Aims to Advance Trump Tax Agenda While Postponing Spending-Cut Fight -- Update

31 mars 2025, 21:02 UTC

Résultats

Freeport-McMoRan Sees 1Q Gold Sales 100,000 Ounces Below Previous Guidance of 225,000 Ounces >FCX

31 mars 2025, 21:01 UTC

Résultats

Freeport-McMoRan Backs 1Q Consolidated Copper Sales of 850M Pounds >FCX

31 mars 2025, 20:50 UTC

Market Talk

Financial Services Roundup: Market Talk

31 mars 2025, 20:50 UTC

Market Talk

Basic Materials Roundup: Market Talk

31 mars 2025, 20:37 UTC

Actualités

A Wild Quarter for U.S. Stocks Sends Investors Abroad -- 3rd Update

31 mars 2025, 20:17 UTC

Actualités

Dow Bounced Back After Tariff Concerns Hit Global Markets -- WSJ

31 mars 2025, 20:13 UTC

Actualités

A Wild Quarter for U.S. Stocks Sends Investors Abroad -- 2nd Update

31 mars 2025, 20:03 UTC

Actualités

A Wild Quarter for U.S. Stocks Sends Investors Abroad -- Update

31 mars 2025, 19:09 UTC

Market Talk

Oil At 5-Week High as Trump Makes More Sanction Threats -- Market Talk

31 mars 2025, 18:56 UTC

Market Talk

U.S. Natural Gas Gains With Help From Weather -- Market Talk

31 mars 2025, 18:54 UTC

Market Talk

Canadian Banks' Fundamentals to Support Credit Ratings Near Term -- Market Talk

31 mars 2025, 18:40 UTC

Market Talk

Walmart's Low Income Consumer Appears Increasingly Strained -- Market Talk

31 mars 2025, 18:34 UTC

Market Talk

Ball, Crown Won't Be Materially Hurt if Soda Kicked Off Food Stamps -- Market Talk

31 mars 2025, 18:28 UTC

Market Talk

Gold Climbs to Close Out Quarter -- Market Talk

31 mars 2025, 18:03 UTC

Actualités

Dow Edges Higher, Tariff Concerns Drag Down Global Markets -- WSJ

Comparaison

Variation de prix

Smith & Nephew PLC prévision

Objectif de Prix

By TipRanks

15.09% hausse

Prévisions sur 12 Mois

Moyen 1,248.7 GBX  15.09%

Haut 1,400 GBX

Bas 1,025 GBX

Basé sur 10 analystes de Wall Street proposant des objectifs de prix à 12 mois pour Microsoft Corp. au cours des 3 derniers mois.

Note du Consensus

By TipRanks

Achat

10 ratings

5

Achat

5

Maintien

0

Vente

Éléments financiers

Frais Généraux et Administratifs

Dépenses d'exploitation

Résultat avant impôt

Ventes

Coût des ventes

Marge brute des ventes

EBITDA

Bénéfice d'exploitation

$

À Propos Smith & Nephew PLC

Smith & Nephew plc, together with its subsidiaries, develops, manufactures, markets, and sells medical devices and services in the United Kingdom and internationally. It operates through three segments: Orthopaedics, Sports Medicine & ENT, and Advanced Wound Management. The company offers knee implant products for knee replacement procedures; hip implants for revision procedures; trauma and extremities products that include internal and external devices used in the stabilization of severe fractures and deformity correction procedures; and other reconstruction products. It also provides sports medicine joint repair products comprise instruments, technologies, and implants to perform minimally invasive surgery, as well as treating soft tissue injuries and degenerative conditions of the shoulder, knee, hip, and small joints. In addition, the company offers arthroscopic enabling technologies comprising fluid management equipment for surgical access, high-definition cameras, digital image capture, scopes, light sources, and monitors to assist with visualization inside the joints, radio frequency, electromechanical and mechanical tissue resection devices, and hand instruments for removing damaged tissue; and ear, nose, and throat solutions. Further, it provides advanced wound care products for the treatment and prevention of acute and chronic wounds, which comprise leg wounds, diabetic and pressure ulcers, burns, and post-operative wounds; advanced wound bioactives, such as biologics and other bioactive technologies for debridement and dermal repair/regeneration, and regenerative medicine products, including skin, bone graft, and articular cartilage substitutes; and advanced wound devices, such as traditional and single-use negative pressure wound therapy, and hydrosurgery systems. The company serves the healthcare providers. Smith & Nephew plc was founded in 1856 and is headquartered in Watford, the United Kingdom.